Target intelligence / Profile preview

Solute carrier family 22 member 6 (Organic anion transporter 1) (SLC22A6)

Target
SLC22A6
Molecular classification
Transporter, Solute carrier family
01

Overview

Solute carrier family 22 member 6 (SLC22A6), commonly known as Organic anion transporter 1 (OAT1), is a transmembrane protein primarily expressed in the basolateral membrane of renal proximal tubule cells (UniProt: P48431). It functions as an organic anion/dicarboxylate exchanger, facilitating the uptake of substrates from the blood into the kidney for subsequent secretion into the urine (PubMed: 23506833). This transporter is essential for the renal clearance of numerous endogenous metabolites and exogenous compounds, including antibiotics, antivirals, and NSAIDs (NIH: Gene ID 9356). Because it handles a wide range of substrates, it is a primary site for clinically significant drug-drug interactions; for instance, probenecid is often used to inhibit OAT1 to reduce the nephrotoxicity of cidofovir or to increase the plasma concentration of penicillins (StatPearls: Probenecid). Genetic variations in the SLC22A6 gene can significantly impact an individual's drug response and susceptibility to toxin-induced kidney damage. Beyond pharmacology, SLC22A6 is involved in the transport of signaling molecules like prostaglandins and metabolic intermediates like alpha-ketoglutarate, linking it to metabolic homeostasis and conditions like hyperuricemia (Wikipedia: SLC22A6). Overall, SLC22A6 is a critical target for understanding pharmacokinetics and ensuring drug safety in clinical development.

Other names
Organic anion transporter 1OAT1Renal organic anion transporter 1ROAT1PAHTHOAT1
02

Mechanism of action

Competitive inhibition of organic anion transport

03

Biological functions

Renal excretionOrganic anion transportXenobiotic metabolismHomeostasis
04

Disease associations

NephrotoxicityChronic kidney diseaseHyperuricemiaDrug-induced kidney injury
05

Safety considerations

Drug-drug interactionsIncreased systemic exposure of co-administered drugsNephrotoxicity
06

Interacting drugs

Probenecid

8 more in the full profile.

07

Biomarkers

Plasma drug concentrationSerum creatinineUrinary organic anions

Beyond the preview

Go deeper on Solute carrier family 22 member 6 (Organic anion transporter 1) (SLC22A6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 22 member 6 (Organic anion transporter 1) (SLC22A6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call